Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.290
+0.040 (1.78%)
At close: Jun 18, 2026, 4:00 PM EDT
2.420
+0.130 (5.68%)
After-hours: Jun 18, 2026, 7:55 PM EDT
Intelligent Bio Solutions Market Cap
Intelligent Bio Solutions has a market cap or net worth of $5.48 million as of June 18, 2026. Its market cap has decreased by -49.83% in one year.
Market Cap
5.48M
Enterprise Value
463.55K
1-Year Change
-49.83%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since December 23, 2020, Intelligent Bio Solutions's market cap has decreased from $108.04M to $5.48M, a decrease of -94.93%. That is a compound annual growth rate of -41.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 5.48M | -39.20% |
| Dec 31, 2025 | 9.01M | 46.68% |
| Dec 31, 2024 | 6.14M | 108.12% |
| Dec 29, 2023 | 2.95M | -19.57% |
| Dec 30, 2022 | 3.67M | -82.82% |
| Dec 31, 2021 | 21.36M | -74.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nexalin Technology | 7.57M |
| Vivos Therapeutics | 6.95M |
| enVVeno Medical | 6.68M |
| HeartSciences | 5.86M |
| Biomerica | 5.53M |
| Beyond Air | 4.75M |
| Bluejay Diagnostics | 4.61M |
| Aethlon Medical | 4.48M |